MDGL CIK: 1157601

Madrigal Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.27
FY22:
0.36
FY23:
0.64
FY24:
1.03
FY25:
1.25
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.00
FY23:
0.00
FY24:
0.01
FY25:
0.01
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.27
FY22:
0.36
FY23:
0.64
FY24:
1.04
FY25:
1.26

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.12
FY23:
0.12
FY24:
0.17
FY25:
0.31
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.05
FY23:
0.12
FY24:
0.12
FY25:
0.35
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.20
FY23:
0.41
FY24:
0.75
FY25:
0.60
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.27
FY22:
0.36
FY23:
0.64
FY24:
1.04
FY25:
1.26

All amounts in billions USD Data source:SEC EDGAR